The GSH-Glo Glutathione Assay GSH Depletion and Recovery in Treated Cells HeLa cells (5000 cells/well in 96 well format) were exposed to l-Buthionine-sulfoximine (BSO)
The powerful ability of Body Protection Compound 157 to heal and help people recover has gotten a lot of attention
Type II collagen-chondroitin sulfate-hyaluronan scaffold cross-linked by genipin for cartilage tissue engineering

To accelerate progress in manufactured islet cell therapies, the panelists agreed that the top priorities are: More companies exploring novel approaches Expanding eligibility criteria for trialsand incoporating the perspectives of the T1D community into regulatory decisionsso we can build more evidence around the safety and efficacy of manufactured islet cell therapies Additional frameworks to help guide the field, like our cell therapies roadmap and upcoming publications from Breakthrough T1D staff around manufacturing and preclinical considerations Optimizing manufacturing processes to reduce costs and ensure access for people who want these therapies Optimizing cell therapy products by reducing or eliminating the need for immunosuppression and finding the best transplant site for survival Brynn Marks, M.D., Senior Director of Medical Affairs, chaired a session about the promise and perspective of islet cell replacement therapies for kids with T1D

The specific combination should be tailored to individual health goals and needs
It lowers inflammatory markers responsible for joint pain and brain fog, providing systemic anti-inflammatory benefits